SkinBioTherapeutics (SBTX) News Today GBX 17.25 -0.38 (-2.13%) As of 06/13/2025 12:26 PM Eastern Add Compare Share Share Headlines Stock AnalysisChartCompetitorsEarningsHeadlinesBuy This Stock SBTX Latest News All Sources Trusted Sources MarketBeat Benzinga Bloomberg GlobeNewswire GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent June 2025 May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 Time Period SkinBioTherapeutics Appoints New Adviser and BrokerMay 22, 2025 | tipranks.comSkinBioTherapeutics (LON:SBTX) Trading Up 10.6% - Here's What HappenedSkinBioTherapeutics (LON:SBTX) Shares Up 10.6% - Here's WhyApril 24, 2025 | marketbeat.comSkinBioTherapeutics Strengthens Leadership Amid Strategic GrowthApril 24, 2025 | msn.comSkinBioTherapeutics First Half 2025 Earnings: UK£0.005 loss per share (vs UK£0.008 loss in 1H 2024)March 29, 2025 | finance.yahoo.comSkinBioTherapeutics (LON:SBTX) Issues Quarterly Earnings ResultsSkinBioTherapeutics (LON:SBTX - Get Free Report) announced its earnings results on Wednesday. The company reported GBX (0.46) (($0.01)) earnings per share (EPS) for the quarter. SkinBioTherapeutics had a negative net margin of 237.95% and a negative return on equity of 115.86%.March 27, 2025 | marketbeat.comSkinBioTherapeutics Expands Share Capital with Warrant ExerciseMarch 20, 2025 | tipranks.comSkinBioTherapeutics (LON:SBTX) Reaches New 52-Week High - Time to Buy?SkinBioTherapeutics (LON:SBTX) Hits New 12-Month High - What's Next?March 12, 2025 | marketbeat.comThe past three years for SkinBioTherapeutics (LON:SBTX) investors has not been profitableDecember 12, 2024 | finance.yahoo.comSkinBioTherapeutics Expands in Skin Health MarketDecember 4, 2024 | tipranks.comSkinBioTherapeutics and Croda Secure Key Commercial DealNovember 19, 2024 | markets.businessinsider.comAIM WINNERS & LOSERS: SkinBioTherapeutics and Oxford Metrics make buysOctober 12, 2024 | lse.co.ukSkinbiotherap. Share Chat (SBTX)September 19, 2024 | lse.co.ukProBiotix Health Plc (PBX.AQ)July 20, 2024 | finance.yahoo.comSkinBioTherapeutics plc (SBTX.L)May 1, 2024 | ca.finance.yahoo.comSkinBioTherapeutics First Half 2024 Earnings: UK£0.008 loss per share (vs UK£0.008 loss in 1H 2023)March 26, 2024 | finance.yahoo.comSkinBioTherapeutics announces research into wound healing bacteriumMarch 18, 2024 | lse.co.ukSkinBioTherapeutics bags £3m at a modest discountNovember 17, 2023 | uk.investing.comSkinBioTherapeutics to Raise at Least $3.7 MlnNovember 16, 2023 | marketwatch.comFiverr International Ltd DRC (F2VR34)September 14, 2023 | uk.investing.comSocietatea de Producere a Energiei Electrice in Hidrocentrale Hidroelectrica SA (ROH2O)September 2, 2023 | uk.investing.comSBTX.L - SkinBioTherapeutics PlcJuly 11, 2023 | finance.yahoo.comSkinBioTherapeutics Gets Approval for Supplement Launch in ItalyJune 21, 2023 | marketwatch.comSkinBioTherapeutics Reports First Half 2023 EarningsMarch 30, 2023 | finance.yahoo.comSkinBioTherapeutics Shares Fall on Widened 1H Pretax Loss From Higher CostsMarch 28, 2023 | marketwatch.comIs SkinBioTherapeutics (LON:SBTX) In A Good Position To Invest In Growth?March 22, 2023 | finance.yahoo.comSkinBioTherapeutics Raises GBP2.6 Mln in Placing, Retail OfferDecember 21, 2022 | marketwatch.comSkinBioTherapeutics to Raise a Minimum of GBP2.5 MlnDecember 15, 2022 | marketwatch.comAfter losing 68% in the past year, SkinBioTherapeutics Plc (LON:SBTX) institutional owners must be relieved by the recent gainOctober 14, 2022 | finance.yahoo.comSkinBioTherapeutics shares fall as probiotic AxisBiotix-PS sales dropAugust 31, 2022 | lse.co.ukSkinBioTherapeutics Shares Fall After Worse-Than-Expected Supplement SalesAugust 31, 2022 | marketwatch.comSkinBioTherapeutics puzzled by share price, says feedback positive for psoriasis treatmentJune 15, 2022 | proactiveinvestors.comSkinBioTherapeutics Knows No Reason For Share Price FallJune 13, 2022 | marketwatch.comWhat It's Like Inside a Burning Drift CarMay 20, 2022 | news.yahoo.comReport raises concerns over lay-offs, cash flow at Cottage clinic; records issues resolvedMay 20, 2022 | news.yahoo.comWe're Keeping An Eye On SkinBioTherapeutics' (LON:SBTX) Cash Burn RateMay 18, 2022 | finance.yahoo.comSkinBioTherapeutics proposes Manprit Singh Randhawa as new CFOMarch 29, 2022 | lse.co.ukSkinBioTherapeutics Shares Drop 30% After Widened 1H Pretax LossMarch 29, 2022 | marketwatch.comWhat Kind Of Shareholders Hold The Majority In SkinBioTherapeutics Plc's (LON:SBTX) Shares?February 17, 2022 | finance.yahoo.comSkinBioTherapeutics CFO to Step DownJanuary 19, 2022 | marketwatch.comSkinBioTherapeutics seeks full-time finance chief and NED to guide social media strategyJanuary 18, 2022 | proactiveinvestors.comSkinBioTherapeutics : Result of AGMDecember 24, 2021 | markets.businessinsider.comSkinBioTherapeutics : Notice of ResultsDecember 4, 2021 | markets.businessinsider.comSkinBioTherapeutics Workflow Disrupted by Pandemic; Shares FallNovember 30, 2021 | marketwatch.comSkinBioTherapeutics : Placing of SharesNovember 22, 2021 | markets.businessinsider.comSkinBioTherapeutics Launches Discounted Share PlacingNovember 15, 2021 | marketwatch.comSkinBioTherapeutics : AxisBiotix-PsT Psoriasis Food Supplement LaunchOctober 15, 2021 | markets.businessinsider.comWhat Type Of Shareholders Own The Most Number of SkinBioTherapeutics Plc (LON:SBTX) Shares?September 2, 2021 | finance.yahoo.com Get SkinBioTherapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for SBTX and its competitors with MarketBeat's FREE daily newsletter. Email Address SBTX Media Mentions By Week SBTX Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. SBTX News Sentiment▼0.000.88▲Average Medical News Sentiment SBTX News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. SBTX Articles This Week▼00▲SBTX Articles Average Week Get SkinBioTherapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for SBTX and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies Bioventix News 4basebio News Avacta Group News Scancell News hVIVO News Ondine Biomedical News Futura Medical News Poolbeg Pharma News Sareum News Arecor Therapeutics News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (LON:SBTX) was last updated on 6/14/2025 by MarketBeat.com Staff From Our PartnersAn AI run of epic proportions is only getting startedI just put together an urgent new presentation that you need to see right away. In short: I believe we are...Timothy Sykes | SponsoredTrump’s Exec Order #14154 could be a “Millionaire-Maker”Former Presidential Advisor, Jim Rickards, says Trump could “rewire our economy and hand millions of Americans...Paradigm Press | SponsoredWhen This Happens, You Don’t Wait. You Act.This same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in cryp...Crypto Swap Profits | SponsoredOil Hits $74 - $100 Next?Oil Jumps 8.5% on Middle East Crisis Trump at Oil Fields Oil surged 8.5% to $74/barrel after Israel's Ir...The Oxford Club | Sponsored[First Look] Get in before potential 10X AI announcementsGo for 10X gains from the next big AI announcement — starting as soon as 7 days from now Former floor trade...Masters in Trading | SponsoredTrump’s treachery Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredAs Bitcoin supply vanishes, this Trump-aligned token could explodeBitcoin's supply is being drained at unprecedented rates, but while most investors focus solely on Bitcoin, th...Crypto 101 Media | SponsoredCollect $7k per month from Tesla’s SECRET dividendI just uncovered a strategy that could pay out up to $7,013 every month—without needing a traditional dividend...Investors Alley | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding SkinBioTherapeutics plc Please log in to your account or sign up in order to add this asset to your watchlist. Share SkinBioTherapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
